Search

everythinglearnresearchcommunity

for

Search:↓

High ornithine decarboxylase levels may lead to hair loss and cancer by increasing CK2 activity in the nucleus.

Noggin promotes skin tumors by activating certain cell signaling pathways.

TAp63 and NRF2 work together to manage oxidative stress, preventing premature aging and aiding skin functions.

Overexpression of HDGF in melanocytes does not cause cancer.

Markers CRABP1, Nestin, and Ephrin B2 are present in skin cancer environments and may influence their development.

Different PADI isoforms help cells develop diverse functions.

Long-term use of finasteride in women can cause hormonal changes, DNA damage, and menstrual issues.

Clinical trials should use innovative designs and biomarkers to improve precision therapy and patient outcomes.

Zinc, copper, and iron are important for skin health and may help diagnose skin diseases.

Hair loss due to scarring can be treated by reducing inflammation, removing scar tissue, and transplanting hair. The Follicular Unit Extraction technique is effective but requires skill and time. Future focus should be on scar-less healing methods.

Fgfr2b helps maintain healthy skin and prevent cancer.

BSSP may help skin tumors grow and could be a marker or target for skin cancer treatment.

Genetics, hormones, and microbiome changes contribute to hidradenitis suppurativa.

Folate receptor β helps suppress the immune system in macrophages and affects cancer growth and hair health.

Activated platelet-rich plasma is a safe and effective treatment for hair loss.

Hair loss in children can be caused by fungal infections, trauma, autoimmune disorders, or stress, and treatments vary depending on the cause.

Subcutaneous trastuzumab improves some symptoms and doesn't harm overall quality of life in breast cancer patients.

Testosterone causes hair loss in AGA mice, which are good for testing baldness treatments, and both minoxidil and cyproterone acetate can prevent this hair loss.

Sex hormones affect hair and feather growth and may help manage alopecia and hormone-dependent cancers.

Men with early hair loss have lower vitamin D levels.

A woman lost all her hair after mild COVID-19, but it started to regrow after treatment with a specific medication.

Finasteride and dutasteride may help prevent hair loss but could cause side effects like sexual dysfunction and psychological issues.

Insulin resistance may contribute to hair loss in people with androgenic alopecia.

Androgenic alopecia, a common hair loss condition, is linked to changes in androgen metabolism and genetics, and can be treated with finasteride and minoxidil, but these treatments are only fully effective in 10% of patients.

Imiquimod can cause rare skin side effects, some irreversible, and long-term follow-up is important for users.

Lipocalin-Type Prostaglandin D2 Synthase (L-PGDS) is a protein that plays many roles in the body, including sleep regulation, pain management, food intake, and protection against harmful substances. It also affects fat metabolism, glucose intolerance, cell maturation, and is involved in various diseases like diabetes, cancer, and arthritis. It can influence sex organ development and embryonic cell differentiation, and its levels can be used as a diagnostic marker for certain conditions.

Discoid Lupus Erythematosus often causes scarring hair loss, is influenced by genetics and environment, and requires early treatment to prevent worsening.

Lef1 helps stem cells become hair cells by interacting with specific signaling pathways.

Blocking JAK/STAT pathways can help treat hair loss from alopecia areata.

Targeting EGFR may help reduce hair loss from chemotherapy.